Skip to content
10-K/A

Annual Report

BIOTRICITY INC. BTCY

0001641172-25-020105

← back to feed
Filed
Jul 18, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jul 15, 2025 26.57M sh
Shares Diluted FY 2025 · Mar 31, 2025 21.52M sh
Shares Diluted FY 2025 · Mar 31, 2024 8.99M sh
Operating Cash Flow FY 2025 · Mar 31, 2025 −$2.38M
Operating Cash Flow FY 2025 · Mar 31, 2024 −$6.69M
Cash And Equivalents FY 2025 · Mar 31, 2025 $365.15K
Cash And Equivalents FY 2025 · Mar 31, 2024 $786.06K
Stockholders Equity FY 2025 · Mar 31, 2025 −$32.01M
Stockholders Equity FY 2025 · Mar 31, 2024 −$31.47M
Stockholders Equity FY 2025 · Mar 31, 2023 −$19.85M
Current Liabilities FY 2025 · Mar 31, 2025 $20.64M
Current Liabilities FY 2025 · Mar 31, 2024 $22.7M
Total Liabilities FY 2025 · Mar 31, 2025 $35.66M
Total Liabilities FY 2025 · Mar 31, 2024 $35.92M
Current Assets FY 2025 · Mar 31, 2025 $4.64M
Current Assets FY 2025 · Mar 31, 2024 $4.47M
Total Assets FY 2025 · Mar 31, 2025 $5.64M
Total Assets FY 2025 · Mar 31, 2024 $5.94M
Eps Diluted FY 2025 · Mar 31, 2025 −$0.56
Eps Diluted FY 2025 · Mar 31, 2024 −$1.66
Eps Basic FY 2025 · Mar 31, 2025 −$0.56
Eps Basic FY 2025 · Mar 31, 2024 −$1.66
Sga Expense FY 2025 · Mar 31, 2025 $10.86M
Sga Expense FY 2025 · Mar 31, 2024 $14.61M
Rd Expense FY 2025 · Mar 31, 2025 $2.16M
Rd Expense FY 2025 · Mar 31, 2024 $2.57M
Net Income FY 2025 · Mar 31, 2025 −$8.42M
Net Income FY 2025 · Mar 31, 2024 −$14.09M
Operating Income FY 2025 · Mar 31, 2025 −$2.45M
Operating Income FY 2025 · Mar 31, 2024 −$8.83M
Gross Profit FY 2025 · Mar 31, 2025 $10.56M
Gross Profit FY 2025 · Mar 31, 2024 $8.36M
Cost Of Revenue FY 2025 · Mar 31, 2025 $3.23M
Cost Of Revenue FY 2025 · Mar 31, 2024 $3.71M
Revenue FY 2025 · Mar 31, 2025 $13.79M
Revenue FY 2025 · Mar 31, 2024 $12.06M